Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases

被引：19
作者：
Fang, Hong [1 ]
Wang, Sa A. [1 ]
Khoury, Joseph D. [1 ]
El Hussein, Siba [1 ]
Kim, Do Hwan [1 ]
Tashakori, Mehrnoosh [1 ]
Tang, Zhenya [1 ]
Li, Shaoying [1 ]
Hu, Zhihong [2 ]
Jelloul, Fatima Zahra [1 ]
Patel, Keyur P. [1 ]
McDonnell, Timothy J. [1 ]
Kadia, Tapan [3 ]
Medeiros, L. Jeffrey [1 ]
Wang, Wei [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Dept Pathol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 09期
关键词：
PROGNOSTIC-SIGNIFICANCE;
D O I：
10.3324/haematol.2021.280487
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2232 / 2237
页数：6
相关论文
共 15 条
  • [1] p53 immunohistochemistry discriminates between pure erythroid leukemia and reactive erythroid hyperplasia
    Alexandres, Christina
    Basha, Basma
    King, Rebecca L.
    Howard, Matthew T.
    Reichard, Kaaren K.
    [J]. JOURNAL OF HEMATOPATHOLOGY, 2021, 14 (01) : 15 - 22
  • [2] Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Bernard, Elsa
    Nannya, Yasuhito
    Hasserjian, Robert P.
    Devlin, Sean M.
    Tuechler, Heinz
    Medina-Martinez, Juan S.
    Yoshizato, Tetsuichi
    Shiozawa, Yusuke
    Saiki, Ryunosuke
    Malcovati, Luca
    Levine, Max F.
    Arango, Juan E.
    Zhou, Yangyu
    Sole, Francesc
    Cargo, Catherine A.
    Haase, Detlef
    Creignou, Maria
    Germing, Ulrich
    Zhang, Yanming
    Gundem, Gunes
    Sarian, Araxe
    van de Loosdrecht, Arjan A.
    Jadersten, Martin
    Tobiasson, Magnus
    Kosmider, Olivier
    Follo, Matilde Y.
    Thol, Felicitas
    Pinheiro, Ronald F.
    Santini, Valeria
    Kotsianidis, Ioannis
    Boultwood, Jacqueline
    Santos, Fabio P. S.
    Schanz, Julie
    Kasahara, Senji
    Ishikawa, Takayuki
    Tsurumi, Hisashi
    Takaori-Kondo, Akifumi
    Kiguchi, Toru
    Polprasert, Chantana
    Bennett, John M.
    Klimek, Virginia M.
    Savona, Michael R.
    Belickova, Monika
    Ganster, Christina
    Palomo, Laura
    Sanz, Guillermo
    Ades, Lionel
    Della Porta, Matteo Giovanni
    Smith, Alexandra G.
    Werner, Yesenia
    [J]. NATURE MEDICINE, 2020, 26 (10) : 1549 - +
  • [3] Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
    Fang, Hong
    Yabe, Mariko
    Zhang, Xiaohui
    Kim, Young
    Wu, Xiaojun
    Wei, Peng
    Chi, Sunyi
    Zheng, Lan
    Garcia-Manero, Guillermo
    Shao, Lina
    Yuan, Ji
    Shen, Yulei
    Zheng, Gang
    Tang, Guiling
    Wang, Wei
    Loghavi, Sanam
    Shen, Qi
    Yuan, Yongzhong
    He, Rong
    Chen, Dong
    Medeiros, L. Jeffrey
    Hu, Shimin
    [J]. MODERN PATHOLOGY, 2021, 34 (06) : 1143 - 1152
  • [4] Prognosis in therapy-related acute myeloid leukemia and impact of karyotype
    Kern, W
    Haferlach, T
    Schnittger, S
    Hiddemann, W
    Schoch, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2510 - 2511
  • [5] THE PROGNOSTIC-SIGNIFICANCE OF PROERYTHROBLASTS IN ACUTE ERYTHROLEUKEMIA
    KOWALVERN, A
    COTELINGAM, J
    SCHUMACHER, HR
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (01) : 34 - 40
  • [6] Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification
    Liu, Wei
    Hasserjian, Robert P.
    Hu, Ying
    Zhang, Liping
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Wang, Sa A.
    [J]. MODERN PATHOLOGY, 2011, 24 (03) : 375 - 383
  • [7] Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients
    Mazzella, FM
    Smith, D
    Horn, P
    Cotelingam, JD
    Rector, JT
    Shrit, MA
    Pesce, A
    Schumacher, HR
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 484 - 491
  • [8] Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Class, Caleb A.
    Sasaki, Koji
    Ravandi, Farhad
    Cortes, Jorge E.
    Daver, Naval
    Takahashi, Koichi
    Short, Nicholas J.
    DiNardo, Courtney D.
    Jabbour, Elias
    Borthakur, Gautam
    Naqvi, Kiran
    Issa, Ghayas C.
    Konopleva, Marina
    Khoury, Joseph D.
    Routbort, Mark
    Pierce, Sherry
    Do, Kim-Anh
    Bueso-Ramos, Carlos
    Patel, Keyur
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 612 - 622
  • [9] More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia
    Montalban-Bravo, Guillermo
    Benton, Christopher B.
    Wang, Sa A.
    Ravandi, Farhad
    Kadia, Tapan
    Cortes, Jorge
    Daver, Naval
    Takahashi, Koichi
    DiNardo, Courtney
    Jabbour, Elias
    Borthakur, Gautam
    Konopleva, Marina
    Pierce, Sherry
    Bueso-Ramos, Carlos
    Patel, Keyur
    Kornblau, Steven
    Kantarjian, Hagop
    Young, Ken H.
    Garcia-Manero, Guillermo
    Andreeff, Michael
    [J]. BLOOD, 2017, 129 (18) : 2584 - 2587
  • [10] Immunohistochemical correlates of TP53 somatic mutations in cancer
    Murnyak, Balazs
    Hortobagyi, Tibor
    [J]. ONCOTARGET, 2016, 7 (40) : 64910 - 64920
12